Can You Buy Scale AI Stock? Pre-IPO Options Explained

Short answer: no, not directly. Scale AI is a private company. There is no ticker, no public share class, and no way to type a symbol into Robinhood, Fidelity, or Schwab and own it. Anyone advertising "SCLE" or a Scale AI ticker is running a scam. The only legitimate routes are (1) buying existing shares from employees or early investors on a pre-IPO secondary marketplace, which requires SEC accredited-investor status, (2) owning a fund that happens to hold Scale, or (3) buying Meta, which paid roughly $14.3 billion in June 2025 for a ~49% non-voting stake. Each route has real costs and real limits. Below is what each actually involves, what it costs, and who should skip it entirely.

Why There's No Ticker: Scale AI's Ownership Structure

Scale AI was founded in 2016 by Alexandr Wang and Lucy Guo, and it sells human-labeled and human-evaluated training data to frontier labs and the U.S. government. It raised a $1 billion Series F in May 2024 at a $13.8 billion valuation, led by Accel with participation from Nvidia, Amazon, Meta, and others.

Then came the deal that changed everything. In June 2025, Meta invested about $14.3 billion for a roughly 49% non-voting stake, valuing Scale near $29 billion — more than double its valuation from roughly 13 months earlier. Alexandr Wang left to run Meta's superintelligence lab. Scale remained a separate company with its own management, and Meta explicitly took *non-voting* shares.

That structure matters for you as a would-be buyer:

Route 1: Pre-IPO Secondary Marketplaces (Accredited Investors Only)

Platforms like Forge Global, EquityZen, Hiive, Nasdaq Private Market, and Augment sometimes list Scale AI shares from former employees. To transact, you must be an accredited investor under SEC Rule 501: $200,000+ in individual income (or $300,000 joint) for the past two years, or $1 million+ in net worth excluding your primary residence. Certain licenses (Series 7, 65, 82) also qualify.

What it actually costs, beyond the share price:

Layered SPVs are the specific trap. In hot private names, shares get sold into an SPV, which sells into another SPV, which sells to you. Each layer takes fees, and by the third layer you may not have any enforceable claim on the underlying stock at all — just a contract with a fund manager.

Route 2: Buying Meta as a Proxy (And Why the Math Disappoints)

This is the only route open to a normal brokerage account with $500 in it, and it's the one most articles hand-wave. Do the arithmetic before you get excited.

Meta's market capitalization sits in the $1.5–1.9 trillion range. Its Scale AI stake cost $14.3 billion. That's roughly 0.8%–1% of Meta's total value. If Scale tripled to $87 billion, Meta's stake would gain ~$28 billion — about 1.5%–1.9% of Meta's market cap, before you account for the fact that Meta's stock moves 2%–3% on an average earnings day and has drawn ~30% drawdowns more than once.

Buying Meta to get Scale AI exposure is like buying a grocery chain because you like one brand of yogurt on the shelf. You'll own it. It just won't matter.

You are buying advertising revenue, Reality Labs losses, and regulatory risk. Scale is a rounding error in that thesis. Own Meta if you want to own Meta.

Route 3: Funds That Hold Private Companies

A handful of vehicles give non-accredited investors indirect private-market exposure — interval funds and closed-end funds such as ARK Venture Fund (ARKVX) and Destiny Tech100 (DXYZ) hold baskets of private names. Verify current holdings on the fund's own website before assuming Scale is in there; positions change quarterly and marketing pages lag.

Two warnings that apply regardless of which fund:

When You Should Not Buy Scale AI Shares

This is the section that costs us nothing to write and might save you a lot. Plainly: most people reading this should not do this.

The Version of This Question Worth Asking If You Run a Service Business

Most people searching this aren't building a venture portfolio. They own an HVAC company, a law firm, a dental practice, or a roofing outfit, they watched AI eat the news cycle, and buying a share felt like the available action.

Here's the uncomfortable comparison. A $25,000 allocation to Scale AI on a secondary might return 2x in five years, minus ~4% platform fees and ~15% carry — call it roughly $40,000 net, in year five, if the company performs and eventually lists.

That same $25,000 deployed operationally looks different. An AI voice agent answering after-hours calls runs roughly $0.07–$0.12 per minute. A GoHighLevel-based CRM with automated follow-up runs $97–$497/month, plus setup. For a business where the average job is $450 and you currently miss calls after 5 p.m., capturing four additional jobs per month is $21,600 a year — recurring, compounding, and yours in 60 days rather than year five. Run your own numbers in our ROI calculator rather than trusting mine.

Neither is universally right. If you have surplus capital, meet the accreditation bar, and can genuinely forget the money for five-plus years, a small private position is a legitimate holding. If the $25,000 is your growth budget, buying illiquid stock in a company whose largest customers just walked is a strange way to bet on AI.

What to Do Next

Scale AI may well be a great company. It's also one you can't buy on reasonable terms, can't value with real financials, can't exit on your schedule, and can't tax-optimize. Knowing that is worth more than a ticker symbol you were never going to get.